Wikidata

(Q86290868)

English

Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure

clinical trial

In more languages

Statements

title
Paclitaxel Plus Cetuximab for the Treatment of Recurrent and/or Metastatic Head and Neck Cancer After First-line Checkpoint Inhibitor Failure: A Multicenter, Single Arm Study (English)
0 references
country
Austria
0 references
start time
February 2020
0 references
end time
December 2021
0 references
number of participants
50
0 references
research intervention
paclitaxel
0 references
cetuximab
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q86290868&oldid=1859135776"